Combining Antibiotics to Fight Resistant Staphylococcus Infections
Author Information
Author(s): Miranda-Novales Guadalupe, Leaños-Miranda Blanca E, Vilchis-Pérez Mariano, Solórzano-Santos Fortino
Primary Institution: Instituto Mexicano del Seguro Social
Hypothesis
The study aims to describe the interaction of beta-lactams in combination with vancomycin or amikacin against resistant Staphylococcus strains.
Conclusion
The study found that amikacin combined with cephalothin or dicloxacillin was effective against most resistant Staphylococcus strains, while vancomycin showed additivity with beta-lactams.
Supporting Evidence
- Dicloxacillin plus amikacin was synergistic in 84.6% of cases.
- Cephalothin plus amikacin was synergistic in 100% of cases.
- Vancomycin plus amikacin showed a synergistic effect only against two isolates.
Takeaway
The researchers tested different combinations of antibiotics to see which worked best against superbugs, and found some combinations were really effective.
Methodology
The study used checkerboard synergy tests to evaluate the effectiveness of various antibiotic combinations against resistant Staphylococcus isolates.
Limitations
The clinical effectiveness of the combinations may not be achievable in practice, and the study was limited to in vitro conditions.
Participant Demographics
The study focused on 26 oxacillin and amikacin-resistant nosocomial Staphylococcus spp. isolates.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website